WA
WestEnd Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7M | Buy |
85,492
+18,950
| +28% | +$7.68M | 0.86% | 33 |
|
|
2025
Q1 | $33.1M | Buy |
66,542
+3,952
| +6% | +$1.97M | 0.88% | 33 |
|
|
2024
Q4 | $32.6M | Sell |
62,590
-7,520
| -11% | -$3.91M | 0.83% | 32 |
|
|
2024
Q3 | $43.4M | Sell |
70,110
-143
| -0.2% | -$88.5K | 1.06% | 27 |
|
|
2024
Q2 | $38.8M | Buy |
70,253
+7,468
| +12% | +$4.13M | 1% | 28 |
|
|
2024
Q1 | $36.5M | Buy |
62,785
+8,745
| +16% | +$5.08M | 0.95% | 26 |
|
|
2023
Q4 | $28.7M | Sell |
54,040
-9,700
| -15% | -$5.15M | 0.79% | 33 |
|
|
2023
Q3 | $32.3M | Buy |
63,740
+5,111
| +9% | +$2.59M | 0.97% | 30 |
|
|
2023
Q2 | $30.6M | Buy |
+58,629
| New | +$30.6M | 0.9% | 31 |
|
|
2023
Q1 | – | Sell |
-58,834
| Closed | -$32.4M | – | 21 |
|
|
2022
Q4 | $32.4M | Sell |
58,834
-3,950
| -6% | -$2.18M | 1.06% | 24 |
|
|
2022
Q3 | $31.8M | Sell |
62,784
-3,517
| -5% | -$1.78M | 1.07% | 26 |
|
|
2022
Q2 | $36M | Buy |
+66,301
| New | +$36M | 1.14% | 25 |
|
|
2022
Q1 | – | Sell |
-3
| Closed | -$2K | – | 76 |
|
|
2021
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 78 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 72 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 81 |
|